SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-23-050236
Filing Date
2023-09-28
Accepted
2023-09-28 07:31:01
Documents
15
Period of Report
2023-09-28
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K rnlx-20230928.htm   iXBRL 8-K 45159
2 EX-99.1 rnlx-ex99_1.htm EX-99.1 1162157
3 GRAPHIC img102423453_0.jpg GRAPHIC 28770
  Complete submission text file 0000950170-23-050236.txt   1476637

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT rnlx-20230928.xsd EX-101.SCH 3146
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT rnlx-20230928_lab.xml EX-101.LAB 18453
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT rnlx-20230928_def.xml EX-101.DEF 15111
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT rnlx-20230928_pre.xml EX-101.PRE 15278
9 EXTRACTED XBRL INSTANCE DOCUMENT rnlx-20230928_htm.xml XML 6073
Mailing Address FINSGATE 5-7 CRANWOOD STREET LONDON X0 EC1V 9EE
Business Address FINSGATE 5-7 CRANWOOD STREET LONDON X0 EC1V 9EE 44 29 2071 0570
Renalytix plc (Filer) CIK: 0001811115 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-39387 | Film No.: 231286154
SIC: 8071 Services-Medical Laboratories